Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03975400|
Recruitment Status : Recruiting
First Posted : June 5, 2019
Last Update Posted : November 21, 2019
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia First Episode Psychosis||Behavioral: search engine advertisement campaign||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||700 participants|
|Intervention Model:||Sequential Assignment|
|Masking:||None (Open Label)|
|Official Title:||Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis|
|Actual Study Start Date :||October 1, 2019|
|Estimated Primary Completion Date :||December 31, 2021|
|Estimated Study Completion Date :||December 31, 2021|
No Intervention: Pre-Campaign
Investigators will measure the duration of untreated psychosis and rates of referrals to OnTrackNY programs throughout New York States prior to campaign initiation.
Active Comparator: Active Campaign
Investigators will measure the duration of untreated psychosis and rates of referrals to OnTrackNY programs throughout New York States during the active campaign initiation.
Behavioral: search engine advertisement campaign
This proposal aims to explore whether targeted and proactive online outreach through search engine advertisements, coupled with engaging, informative, and interactive online resources, can effectively reduce the duration of untreated psychosis and facilitate earlier treatment initiation in New York State.
- Reducing the duration of untreated psychosis [ Time Frame: 2 years ]Evaluate the effectiveness of a search engine ad campaign on reducing DUP and raising rates of FEP referrals by directly comparing DUP and FEP referrals pre-campaign to DUP and FEP referrals during the campaign.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03975400
|Contact: Michael L Birnbaum, MDemail@example.com|
|United States, New York|
|Northwell||Not yet recruiting|
|Glen Oaks, New York, United States, 11004|
|Queens, New York, United States, 11004|
|Contact: Michael Birnbaum|
|Principal Investigator:||Michael L Birnbaum, MD||Northwell Health|